IL155574A0 - Treatment of pcp addiction and pcp addiction-related behavior - Google Patents

Treatment of pcp addiction and pcp addiction-related behavior

Info

Publication number
IL155574A0
IL155574A0 IL15557401A IL15557401A IL155574A0 IL 155574 A0 IL155574 A0 IL 155574A0 IL 15557401 A IL15557401 A IL 15557401A IL 15557401 A IL15557401 A IL 15557401A IL 155574 A0 IL155574 A0 IL 155574A0
Authority
IL
Israel
Prior art keywords
pcp addiction
treatment
pcp
addiction
related behavior
Prior art date
Application number
IL15557401A
Other languages
English (en)
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of IL155574A0 publication Critical patent/IL155574A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Addiction (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL15557401A 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior IL155574A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/694,040 US6395783B1 (en) 2000-10-23 2000-10-23 Treatment of PCP addiction and PCP addiction-related behavior
PCT/US2001/007233 WO2002034249A1 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior

Publications (1)

Publication Number Publication Date
IL155574A0 true IL155574A0 (en) 2003-11-23

Family

ID=24787164

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15557401A IL155574A0 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior
IL155574A IL155574A (en) 2000-10-23 2003-04-24 Use of Gamma Vinyl GABA for the Preparation of a Drug for the Treatment of PCP Addiction and Behavior Related to This Addiction

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155574A IL155574A (en) 2000-10-23 2003-04-24 Use of Gamma Vinyl GABA for the Preparation of a Drug for the Treatment of PCP Addiction and Behavior Related to This Addiction

Country Status (17)

Country Link
US (1) US6395783B1 (enExample)
EP (1) EP1335717A4 (enExample)
JP (1) JP2004512301A (enExample)
KR (1) KR20030074610A (enExample)
CN (2) CN1771929A (enExample)
AU (2) AU4201101A (enExample)
BR (1) BR0114898A (enExample)
CA (1) CA2426210C (enExample)
CZ (1) CZ20031431A3 (enExample)
HR (1) HRP20030322A2 (enExample)
HU (1) HUP0301441A3 (enExample)
IL (2) IL155574A0 (enExample)
MX (1) MXPA03003589A (enExample)
NO (1) NO20031814L (enExample)
NZ (1) NZ526072A (enExample)
PL (1) PL361028A1 (enExample)
WO (1) WO2002034249A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN114903006B (zh) * 2021-02-09 2024-08-02 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物物质成瘾模型的构建方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133002B (en) 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4595697A (en) 1984-03-28 1986-06-17 Merrell Dow Pharmaceuticals Inc. Treatment of seizure disorders and pharmaceutical compositions useful therein
US5189064A (en) 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
EP0381696B1 (en) 1987-10-07 1993-07-28 Matrix Technologies, Inc. Pharmaceutical composition for the treatment of cocaine addiction
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
HUP0100115A2 (hu) 1997-10-28 2001-06-28 Schering Corp. Eljárás kóros vágy csökkentésére emlősökben
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
ES2238999T3 (es) 1999-02-24 2005-09-16 University Of Cincinnati Uso de derivados de sulfamato para tratar trastornos en el control de los impulsos.

Also Published As

Publication number Publication date
HUP0301441A3 (en) 2011-07-28
WO2002034249A1 (en) 2002-05-02
CA2426210A1 (en) 2002-05-02
CN1234352C (zh) 2006-01-04
HRP20030322A2 (en) 2005-02-28
AU4201101A (en) 2002-05-06
EP1335717A1 (en) 2003-08-20
IL155574A (en) 2010-02-17
NZ526072A (en) 2004-08-27
AU2001242011B2 (en) 2005-11-03
CA2426210C (en) 2009-12-22
NO20031814L (no) 2003-06-19
US6395783B1 (en) 2002-05-28
KR20030074610A (ko) 2003-09-19
CN1771929A (zh) 2006-05-17
PL361028A1 (en) 2004-09-20
HUP0301441A2 (hu) 2003-11-28
CZ20031431A3 (cs) 2004-06-16
JP2004512301A (ja) 2004-04-22
MXPA03003589A (es) 2005-08-16
NO20031814D0 (no) 2003-04-23
CN1476326A (zh) 2004-02-18
AU2001242011B8 (en) 2006-03-02
BR0114898A (pt) 2003-08-12
EP1335717A4 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
HUP0103377A3 (en) Treatment of addiction and addiction-related behavior
AU7593001A (en) Alpha-msh related compounds and methods of use
AU1166502A (en) Human ect2 and methods of use
AU6118001A (en) Combination therapeutic compositions and methods of use
EP1385434A4 (en) TREATMENT OF CERVICAL EPROLAPS
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0210645D0 (en) Underreamer and method of use
AU4976001A (en) Mucin-1 specific binding members and methods of use thereof
GB2362070B (en) Communication devices and method of communication
GB0010983D0 (en) Communication devices and method of communication
AU8878801A (en) Agent and method of prevention and treatment of cancer in animals
SG103292A1 (en) Developing treatment method and developing treatment unit
AU8235601A (en) Dispenser and method of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2003277265A8 (en) Punctum dilating and punctum plug insertion instrument
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
AU2002324895A8 (en) Cosmetic kit and method
AU5000001A (en) Treatment of vitiligo
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
IL155574A0 (en) Treatment of pcp addiction and pcp addiction-related behavior
EP1317271A4 (en) THERAPEUTIC AND COSMETIC USES OF HEPARANASES
SG90719A1 (en) Novel therapeutic and prophylactic agents and methods of using same
GB2363981B (en) Assemblies of Case-holder and Case
GB0127006D0 (en) Treatment of moccasion seam
AU6884801A (en) Therapeutic compounds and methods